Background: Intravenous glucocorticoid (GC) has been proposed to treat moderately severe Graves’ orbitopathy (GO); however, the optimal regime remains debatable. We therefore performed this network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results